Keri N Althoff

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. doi request reprint Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men
    Keri N Althoff
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Rm E7142, Baltimore, MD 21205
    J Gerontol A Biol Sci Med Sci 69:189-98. 2014
  2. pmc U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland, USA
    Ann Intern Med 157:325-35. 2012
  3. pmc CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?
    Keri N Althoff
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA
    AIDS Res Ther 7:45. 2010
  4. pmc Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability
    Keri N Althoff
    Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    AIDS 25:1229-32. 2011
  5. pmc Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons
    Keri N Althoff
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA
    Prev Med 50:223-9. 2010
  6. pmc Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009
    David B Hanna
    Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 56:1174-82. 2013
  7. pmc Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009
    David B Hanna
    Johns Hopkins University, Baltimore, Maryland, United States of America Albert Einstein College of Medicine, Bronx, New York, United States of America
    PLoS ONE 8:e78952. 2013
  8. pmc Late presentation for human immunodeficiency virus care in the United States and Canada
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 50:1512-20. 2010
  9. pmc Retention among North American HIV-infected persons in clinical care, 2000-2008
    Peter Rebeiro
    Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 62:356-62. 2013
  10. pmc Virologic and immunologic response to HAART, by age and regimen class
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland 21287, USA
    AIDS 24:2469-79. 2010

Detail Information

Publications14

  1. doi request reprint Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men
    Keri N Althoff
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Rm E7142, Baltimore, MD 21205
    J Gerontol A Biol Sci Med Sci 69:189-98. 2014
    ..The objective of this study was to evaluate the expression and predictors of the frailty phenotype (FP) among HIV-infected (HIV+) and HIV-uninfected (HIV-) men who have sex with men...
  2. pmc U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland, USA
    Ann Intern Med 157:325-35. 2012
    ..The U.S. National HIV/AIDS Strategy targets for 2015 include "increasing access to care and improving health outcomes for persons living with HIV in the United States" (PLWH-US)...
  3. pmc CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?
    Keri N Althoff
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA
    AIDS Res Ther 7:45. 2010
    ..10%, respectively). Due to the increasing proportion, consistently lower CD4 counts, and more advanced HIV disease in adults ≥50-year-old at first presentation for HIV care, renewed HIV testing efforts are needed...
  4. pmc Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability
    Keri N Althoff
    Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    AIDS 25:1229-32. 2011
    ..Owing to evidence showing a greater risk of influenza-related complications, HIV-infected individuals should continue to be a priority group for vaccination...
  5. pmc Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons
    Keri N Althoff
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA
    Prev Med 50:223-9. 2010
    ..To estimate the cumulative incidence of self-reported influenza vaccination ("vaccination coverage") and investigate predictors in HIV-infected women...
  6. pmc Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009
    David B Hanna
    Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 56:1174-82. 2013
    ..We sought to examine trends in treatment initiation and resulting human immunodeficiency virus (HIV) virologic suppression in North America between 2001 and 2009, and demographic and geographic disparities in these outcomes...
  7. pmc Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009
    David B Hanna
    Johns Hopkins University, Baltimore, Maryland, United States of America Albert Einstein College of Medicine, Bronx, New York, United States of America
    PLoS ONE 8:e78952. 2013
    ..States differ regarding their financial contributions to and ways of implementing these programs, and it remains unclear how this interstate variability affects HIV treatment outcomes...
  8. pmc Late presentation for human immunodeficiency virus care in the United States and Canada
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 50:1512-20. 2010
    ..CONCLUSION. CD4 count at first presentation for HIV care has increased annually over the past 11 years but has remained <350 cells/mm(3), which suggests the urgent need for earlier HIV diagnosis and treatment...
  9. pmc Retention among North American HIV-infected persons in clinical care, 2000-2008
    Peter Rebeiro
    Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 62:356-62. 2013
    ..Retention in care is key to improving HIV outcomes. The goal of this study was to describe 'churn' in patterns of entry, exit, and retention in HIV care in the United States and Canada...
  10. pmc Virologic and immunologic response to HAART, by age and regimen class
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland 21287, USA
    AIDS 24:2469-79. 2010
    ..To determine the impact of age and initial HAART regimen class on virologic and immunologic response within 24 months after initiation...
  11. doi request reprint Disparities in the Quality of HIV Care When Using US Department of Health and Human Services Indicators
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland
    Clin Infect Dis 58:1185-9. 2014
    ..Interventions are needed to reduce retention- and treatment-related disparities. ..
  12. pmc Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity
    Allison M McFall
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY Department of Community Health Sciences, State University of New York Downstate Medical Center, Brooklyn, NY Department of Medicine, Georgetown University Medical Center, Washington, DC Department of Medicine, University of California San Francisco, San Francisco, CA Department of Medicine and the CORE Center, Cook County Health and Hospitals System, Chicago, IL and Rush University, Chicago, IL
    J Acquir Immune Defic Syndr 64:289-98. 2013
    ..Stark racial/ethnic disparities in health outcomes exist among those living with HIV in the United States. One of 3 primary goals of the National HIV/AIDS Strategy is to reduce HIV-related disparities and health inequities...
  13. doi request reprint Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines
    Amritha Ramakrishnan
    Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Cytokine 60:661-6. 2012
    ..Collectively, these data suggest that cytokines may influence vaccine outcomes and indicate that parenteral immunization with TIV induces a sustained, systemic cytokine response which lasts for weeks...
  14. pmc Correlates of cervicovaginal human papillomavirus detection in perimenopausal women
    Keri N Althoff
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA
    J Womens Health (Larchmt) 18:1341-6. 2009
    ..The aim of this research was to determine correlates of prevalent cervicovaginal human papillomavirus (HPV) infection in perimenopausal women...